NANOTOX
DEAD

Serial Number

78658566

Owner

nanoLife Sciences, Inc.

Attorney

Tamsen V. Valoir

Filing Date

Jun 27, 2005

Add to watchlist:

No watchlists yet
View on USPTO

NANOTOX Trademark

Serial Number: 78658566

NANOTOX is a trademark filed by nanoLife Sciences, Inc. on June 27, 2005. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently no longer active.

Owner Contact Info

nanoLife Sciences, Inc. (3 trademarks)

P.O. Box 1548
Austin, TX 787671548

Entity Type: 03

Trademark Details

Filing Date

June 27, 2005

Registration Date

Not Registered

Published for Opposition

August 21, 2007

Goods & Services

Scientific apparatus, instruments and devices for research and examination purposes, namely, lab-on-a-chip devices for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; gene microarrays for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; biosensors using chemical, electrochemical, biochemical, enzymatic, chromatographic, spectroscopic, or mass spectral detection methods for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; computers programmed with relational or expert databases of nanoscale material identification or assessment information for use in identification or assessment of nanoscale materials or biological interactions with nanoscale materials; laboratory equipment, measuring apparatus and instruments, namely, nanoscale material generation systems for introduction of nanoscale materials into physical, chemical, biochemical, or biological test systems comprised of dust generators for generating in vitro and in vivo exposures to nanoparticulates for inhalation exposures at toxicologic, pharmacologic, or therapeutic airborne concentrations, vaporizers, nebulizers and sprayers all for use in generating in vitro and in vivo exposures to droplets and other particles containing nanomaterials for inhalation exposures at toxicologic, pharmacologic or therapeutic concentrations, mixers for preparing test materials in solution, semi-solids or solids for exposures or doses of nanomaterials in vitro or in vivo experimental tests of a biological or clinical nature, incubators for creating and maintaining controlled test environments; pipettors, syringes and containers and containment devices designed to retain, and deliver nanomaterials in liquid, semi-solid or solid dosage forms and for chemical analysis of dosage forms and biological samples from toxicologic or pharmacologic exposures in vitro and in vivo, and microplates designed to contain nanomaterials to avoid physicochemical, chemical, physical or electromagnetic effects that would interfere with precise measurements of toxicologic or pharmacologic endpoints; photometric test systems for use in the identification or assessment of nanoscale materials comprised of microplate readers, photomicroscopes, uv/vis photometers and photometric detectors, infrared photometers, photometric detectors, x-ray, gamma-ray, photo fluorescence and magnetic resonance imaging equipment; environmental sampling devices or systems for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials comprised of dust and particulate impact collectors, electrostatic precipitators, water filtration collectors, centrifugal collection devices, air filtration devices and collectors, size exclusion separators, mass spectrometric air sampling systems comprised of mass selective or multiple detectors; photometric air and water sampling systems comprised of air or water sampling chambers with infrared, visible, ultraviolet, fluorescent or laser photometric means of nanoparticulate detection, x-ray diffraction and x-ray fluorescence sampling systems comprised of a variable x-ray source, nanomaterials containment or targeting device and an x-ray detector, liquid and chromatographic sampling systems comprised of an electronically or hydraulically controlled liquid sampling loop to deliver nanomaterials and a microprocessor-controlled microplate or vial in rack-type sample collector

Biological preparations for toxicologic and pharmacologic analysis purposes; chemical preparations for toxicological evaluation of nanomaterials and nanodevices; nanomaterial preparations for medical use; diagnostic preparations for medical use

Biological preparations for scientific research purposes, namely, tissues or cell lines for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; proteins, peptides, or enzymes for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; chemical test kits containing tissues, cell lines, proteins, peptides, or enzymes for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; chemical preparations for scientific analysis purposes, namely, reagents for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; test kits containing chemical reagents for use in the identification or assessment of nanoscale materials or biological interactions with nanoscale materials; chemical formulations for the solubilization, stabilization, or activation of nanoscale materials for use in presentation of nanoscale materials to various biological, physical, or chemical test systems to facilitate identification or assessment of nanoscale materials or biological interactions with nanoscale materials; diagnostic preparations for scientific use

Filing History

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 22, 2010 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 22, 2010 REAP
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
May 17, 2010 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 17, 2010 ABN6
SOU EXTENSION 3 GRANTED
Nov 10, 2009 EX3G
DIVISIONAL PROCESSING COMPLETE
Nov 10, 2009 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 5, 2009 AITU
SOU EXTENSION 3 FILED
Oct 15, 2009 EXT3
DIVISIONAL REQUEST RECEIVED
Oct 15, 2009 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Oct 15, 2009 ERTD
SOU TEAS EXTENSION RECEIVED
Oct 15, 2009 EEXT
SOU EXTENSION 2 GRANTED
Apr 15, 2009 EX2G
SOU EXTENSION 2 FILED
Apr 15, 2009 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 15, 2009 EEXT
SOU EXTENSION 1 GRANTED
Oct 14, 2008 EX1G
SOU EXTENSION 1 FILED
Oct 14, 2008 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 14, 2008 EEXT
EXPARTE APPEAL TERMINATED
Jun 22, 2008 EXPT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Apr 15, 2008 NOAM
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 20, 2008 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 20, 2008 REAP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Mar 4, 2008 ETOP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 29, 2008 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 29, 2008 COAR
POST PUBLICATION AMENDMENT - ENTERED
Jan 24, 2008 CHPB
ASSIGNED TO PETITION STAFF
Jan 24, 2008 APET
PAPER RECEIVED
Dec 4, 2007 MAIL
EXTENSION OF TIME TO OPPOSE RECEIVED
Sep 17, 2007 ETOF
PUBLISHED FOR OPPOSITION
Aug 21, 2007 PUBO
NOTICE OF PUBLICATION
Aug 1, 2007 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 14, 2007 PREV
ASSIGNED TO LIE
May 12, 2007 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 25, 2007 CNSA
EXAMINERS AMENDMENT MAILED
Apr 25, 2007 CNEA
EXAMINER'S AMENDMENT ENTERED
Apr 24, 2007 XAEC
EXAMINERS AMENDMENT -WRITTEN
Apr 24, 2007 CNEA
EXAMINERS AMENDMENT MAILED
Apr 19, 2007 CNEA
EXAMINER'S AMENDMENT ENTERED
Apr 19, 2007 XAEC
EXAMINERS AMENDMENT -WRITTEN
Apr 19, 2007 CNEA
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Mar 23, 2007 JURT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 19, 2007 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 19, 2007 TROA
EX PARTE APPEAL-INSTITUTED
Jan 19, 2007 EXPI
EXPARTE APPEAL RECEIVED AT TTAB
Jan 19, 2007 EXAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 18, 2007 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 18, 2007 REAP
FINAL REFUSAL E-MAILED
Jul 19, 2006 GNFR
FINAL REFUSAL WRITTEN
Jul 19, 2006 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 11, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 5, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 5, 2006 TROA
NON-FINAL ACTION E-MAILED
Jan 19, 2006 GNRT
NON-FINAL ACTION WRITTEN
Jan 19, 2006 CNRT
ASSIGNED TO EXAMINER
Jan 18, 2006 DOCK
NEW APPLICATION ENTERED
Jul 1, 2005 NWAP